Lactobacillus brevis T2102 suppresses the growth of colorectal cancer cells by activating SIRT1

Gakuro Harada, Pawat Pattarawat, Kenji Ito, Takashi Matsumoto, Takanori Hasegawa, Yoshinori Katakura

研究成果: ジャーナルへの寄稿学術誌査読

12 被引用数 (Scopus)


SIRT1 is known to have critical functions in the maintenance of homeostasis and cell survival, and it confers anti-ageing effects on cells and tissues. To identify novel foods and food ingredients with potential anti-ageing functions, a novel system for screening substances that activate the SIRT1 promoter in human colorectal cancer cells was established. We screened several lactic acid bacteria (LAB) and identified Lactobacillus brevis T2102 as a SIRT1-activating strain of LAB. T2102 inactivated β-catenin through SIRT1-mediated deacetylation and consequently suppressed the growth of the human colorectal cancer cell line DLD-1. Furthermore, T2102-induced degradation of β-catenin repressed transcription of the human telomerase reverse transcriptase (hTERT) gene, one of the target genes of β-catenin, which led to the induction of cellular senescence and concomitant growth suppression of DLD-1. These results indicate that SIRT1-activating T2102 might be a promising candidate for developing novel functional foods with anti-cancer properties.

ジャーナルJournal of Functional Foods
出版ステータス出版済み - 5月 1 2016

!!!All Science Journal Classification (ASJC) codes

  • 食品科学
  • 医学(その他)
  • 栄養および糖尿病


「Lactobacillus brevis T2102 suppresses the growth of colorectal cancer cells by activating SIRT1」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。